TIMENTIN Drug Patent Profile
✉ Email this page to a colleague
When do Timentin patents expire, and when can generic versions of Timentin launch?
Timentin is a drug marketed by Glaxosmithkline and is included in three NDAs.
The generic ingredient in TIMENTIN is clavulanate potassium; ticarcillin disodium. There are twenty-seven drug master file entries for this compound. Additional details are available on the clavulanate potassium; ticarcillin disodium profile page.
Summary for TIMENTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TIMENTIN at DailyMed |
Recent Clinical Trials for TIMENTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Osprey Medical, Inc | Phase 2 |